"It will also help identify the patients unlikely to deteriorate, who can be safely discharged.
"Importantly, the AUS-COVID study will provide information on the safety of continuing common cardiac medications for patients with COVID-19.
"This is a really important national study which we believe will assist the large numbers of people with cardiovascular disease in Australia."
Matthew Gray, who was diagnosed with heart disease two years ago has welcomed the research.
"It’s a timely, landmark study which will help fill the gaps in knowledge, and assist GPs and clinicians to better manage people with heart disease who develop Covid," he said.
"As a result of the study, there will be reliable information which will directly help me mange my health."
Researchers from hospitals across Australia have been quick to become involved, demonstrating the urgent need for information about the implications of COVID-19.
The AUS-COVID study is receiving financial support from the Northern Sydney Local Health District and the Ramsay Hospital Research Foundation.